1,269
Views
91
CrossRef citations to date
0
Altmetric
Research Article

Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines

& ORCID Icon
Pages 1117-1127 | Received 17 Nov 2017, Accepted 22 Jan 2018, Published online: 09 Feb 2018

References

  • Alhijjaj M, Belton P, Qi S. 2016. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur J Pharm Biopharm. 108:111–125.
  • Beck RCR, Chaves PS, Goyanes A, Vukosavljevic B, Buanz A, Windbergs M, Basit AW, Gaisford S. 2017. 3D printed tablets loaded with polymeric nanocapsules: an innovative approach to produce customized drug delivery systems. Int J Pharm. 528:268–279.
  • Cernosek Z, Holubová E, Cernoskova E, Liska M. 2002. Enthalpic relaxation and the glass transition. J Optoelectron Adv M. 4:489–503.
  • Cleek RL, Ting KC, G. Eskin S, Mikos AG. 1997. Microparticles of poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J Control Release. 48:259–268.
  • Costa PF, Puga AM, Díaz-Gomez L, Concheiro A, Busch DH, Alvarez-Lorenzo C. 2015. Additive manufacturing of scaffolds with dexamethasone controlled release for enhanced bone regeneration. Int J Pharm. 496:541–550.
  • Desai D, Sandhu H, Shah N, Malick W, Zia H, Phuapradit W, Vaka SRK. 2018. Selection of solid-state plasticizers as processing aids for hot-melt extrusion. J Pharm Sci. 107:372–379.
  • Genina N, Holländer J, Jukarainen H, Mäkilä E, Salonen J, Sandler N. 2016. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur J Pharm Sci. 90:53–63.
  • Giannatsis J, Dedoussis V. 2009. Additive fabrication technologies applied to medicine and health care: a review. Int J Adv Manuf Technol. 40:116–127.
  • Gomaa E, Abu Lila AS, Hasan AA, Ghazy FES. 2018. Preparation and characterization of intravaginal vardenafil suppositories targeting a complementary treatment to boost in vitro fertilization process. Eur J Pharm Sci. 111:113–120.
  • Goyanes A, Buanz ABM, Basit AW, Gaisford S. 2014. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 476:88–92.
  • Goyanes A, Buanz ABM, Hatton GB, Gaisford S, Basit AW. 2015. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 89:157–162.
  • Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S. 2016. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. J Control Release. 234:41–48.
  • Goyanes A, Robles Martinez P, Buanz A, Basit AW, Gaisford S. 2015. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 494:657–663.
  • Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW. 2015. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharmaceutics. 12:4077–4084.
  • Güres S, Kleinebudde P. 2011. Dissolution from solid lipid extrudates containing release modifiers. Int J Pharm. 412:77–84.
  • Hancock BC, Zografi G. 1994. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm Res. 11:471–477.
  • Hernandes RJ. 2009. Polymer Properties. In: Yam KL, editor. The Wiley encyclopedia of packaging technology. 3 ed. Hoboken (NJ): John Wiley & Sons; p. 993–1000.
  • Khaled SA, Burley JC, Alexander MR, Roberts CJ. 2014. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int J Pharm. 461:105–111.
  • Kranz H, Jürgens K, Pinier M, Siepmann J. 2009. Drug release from MCC- and carrageenan-based pellets: experiment and theory. Eur J Pharm Biopharm. 73:302–309.
  • Kucera SA, Felton LA, McGinity JW. 2013. Physical aging in pharmaceutical polymers and the effect on solid oral dosage form stability. Int J Pharm. 457:428–436.
  • Lin SY, Yu HL. 2000. Microscopic Fourier transform infrared/differential scanning calorimetry system used to study the different thermal behaviors of polymethacrylate copolymers of Eudragits RS, RL, E 30D, or E. J Appl Polym Sci. 78:829–835.
  • Ma D, Djemai A, Gendron CM, Xi H, Smith M, Kogan J, Li L. 2013. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME). Drug Dev Ind Pharm. 39:1070–1083.
  • Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema L. 2016. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int J Pharm. 509:255–263.
  • Miralles MJ, McGinty JW, Martin A. 1982. Combined water-soluble carriers for coprecipitates of tolbutamide. J Pharm Sci. 71:302–304.
  • Monograph 00299: theophylline. 2017a. European Pharmacopoeia 9.0 ed. Strasbourg: European Dirctorate for the Quality of Medicines & HealthCare; p. 3750–3751.
  • Monograph 02081: ammonio methacrylate copolymer: type A. 2017b. European Pharmacopoeia 9.0 ed. Strasbourg: European Dirctorate for the Quality of Medicines & HealthCare; p. 1712–1713.
  • Moulton SE, Wallace GG. 2014. 3-dimensional (3D) fabricated polymer based drug delivery systems. J Control Release. 193:27–34.
  • Nellore RV, Singh RG, Hussain AS, Tillman LG, Augsburger LL. 1998. Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration. J Control Release. 50:247–256.
  • Okwuosa TC, Pereira BC, Arafat B, Cieszynska M, Isreb A, Alhnan MA. 2017. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res. 34:427–437.
  • Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan K-W, Alhnan MA. 2016. A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm Res. 33:2704–2712.
  • Park JB, Lee BJ, Kang CY, Tiwari RV, Repka MA. 2017. Process analytical quality control of tailored drug release formulation prepared via hot-melt extrusion technology. J Drug Deliv Sci Technol. 38:51–58.
  • Petzold R, Zeilhofer HF, Kalender WA. 1999. Rapid protyping technology in medicine-basics and applications. Comput Med Imaging Graph. 23:277–284.
  • Pietrzak K, Isreb A, Alhnan MA. 2015. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 96:380–387.
  • Rauwendaal C. 2014. Polymer extrusion. 5th ed. Munich: Carl Hanser Verlag.
  • Sadia M, Sośnicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, Alhnan MA. 2016. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int J Pharm. 513:659–668.
  • Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW. 2008. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets. Int J Pharm. 361:158–168.
  • Simha R, Boyer RF. 1962. On a general relation involving the glass temperature and coefficients of expansion of polymers. J Chem Phys. 37:1003–1007.
  • Skowyra J, Pietrzak K, Alhnan MA. 2015. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci. 68:11–17.
  • Sun Y, Soh S. 2015. Printing tablets with fully customizable release profiles for personalized medicine. Adv Mater Weinheim. 27:7847–7853.
  • Teng Y, Qiu Z, Wen H. 2009. Systematical approach of formulation and process development using roller compaction. Eur J Pharm Biopharm. 73:219–229.
  • Thakral S, Thakral NK, Majumdar DK. 2013. Eudragit: a technology evaluation. Expert Opin Drug Deliv. 10:131–149.
  • Verreck G. 2012. The influence of plasticizers in hot-melt extrusion. In: Douroumis D, editor. Hot-melt extrusion: pharmaceutical applications. 1st ed. Chichester: John Wiley & Sons Ltd.; p. 93–112.
  • Wu C, McGinity JW. 2003. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit® RS PO hot-melt extrudates. Eur J Pharm Biopharm. 56:95–100.
  • Zhang J, Feng X, Patil H, Tiwari RV, Repka MA. 2017a. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm. 519:186–197.
  • Zhang J, Yang W, Vo AQ, Feng X, Ye X, Kim DW, Repka MA. 2017b. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: structure and drug release correlation. Carbohydr Polym. 177:49–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.